Matinas BioPharma Hldgs Q3 EPS $(0.03), Inline

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

Benzinga · 11/13/2019 11:31

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year.